Honors and Awards
Positive Leadership Award, National Association of People with AIDS, 2011
POZ 100 AIDS Fighters, POZ Magazine, 2010
Member, Baltimore City AIDS Commission
Member, Presidential Advisory Council on HIV/AIDS
Member, Delta Omega Honorary Public Health Society, 2006
Student Government Association Professor of the Year, Rollins School of Public Health, Emory University, 2005
Woodruff Leadership Academy Fellow, Woodruff Health Sciences Center, Emory University, 2004
Appointed to Senior Biomedical Research Service, Centers for Disease Control and Prevention, 1997
C. Everett Koop National Health Award, The Health Project, 1996
Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS Stategy in the United States: A closing window for success? AIDS and Behavior 2012, Epub ahead of print.
Holtgrave DR, Wolitski RJ, Pals SL, et al. Cost-utility analysis of the Housing and Health Intervention for homeless and unstably housed persons living with HIV. AIDS and Behavior 2012, Epub ahead of print.
Holtgrave DR, Hall HI, Prejean J. HIV transmission rates in the United States, 2006-2008. Open AIDS Journal 2012;6:26-28.
Holtgrave DR, Maulsby C, Wehrmeyer L, Hall HI. Behavioral factors in assessing impact of HIV treatment as prevention. AIDS and Behavior 2012;16:1085-1091.
Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012;26:893-896.
Holtgrave DR, Maulsby C, Kharfen M, et al. Cost-utility analysis of a female condom promotion program in Washington, DC. AIDS and Behavior 2012;16:1115-1120.
Chander G, Stanton C, Hutton HE, Abrams DB, Pearson J, Knowlton A, Latkin C, Holtgrave D, Moore RD, Niaura R. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS & Behavior 2012;16:383-388.
German D, Sifakis F, Maulsby C, Towe VL, Flynn CP, Latkin CA, Celentano DD, Hauck H, Holtgrave DR. Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: The BESURE Study. Journal of Acquired Immune Deficiency Syndromes 2011;57:77-87.
Holtgrave DR. On the epidemiologic and economic importance of the National AIDS Strategy for the United States. Journal of Acquired Immune Deficiency Syndromes 2010;55:139-142.
Hall HI, Green TA, Wolitski RJ, Holtgrave DR, Rhodes P, Lehman JS, Durden T, Fenton KA, Mermin JH. Estimated future HIV prevalence, incidence, and potential infections averted in the United States: a multiple scenario analysis. Journal of Acquired Immune Deficiency Syndromes 2010;54:565-567.
Holtgrave DR. Potential and limitations of a 'test and treat' strategy as HIV prevention in the United States. International Journal of Clinical Practice 2010;64:678-681.
Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, Holtgrave DR, Harre D, Courtenay-Quirk C for the Housing and Health Study Team. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS & Behavior 2010;14:493-503.
Holtgrave DR. Apparent declines in the global HIV transmission rate. International Journal of STD and AIDS 2009;20:876-878.
Holtgrave DR. Strategies for preventing HIV transmission. Journal of the American Medical Association 2009;302:1530-1531 (editorial).
Holtgrave DR, Wunderink KA, Vallone DM, Health CG. Cost-utility analysis of the nation truth(r) campaign to prevent youth smoking. American Journal of Preventive Medicine 2009;36:385-388.
Holtgrave DR. Written testimony on HIV/AIDS incidence and prevention, September 16, 2008. Washington DC: US House of Representatives Committee on Oversight and Government Reform (Congressional Record).
Bleakley A, Fishbein M, Holtgrave DR. An assessment of the relationship between condom labels and HIV-related beliefs and intentions. AIDS & Behavior 2008;12:452-458.
Holtgrave DR. When "heightened" means "lessened":The case of HIV prevention resources in the United States. Journal of Urban Health 2007;84:648-652.
Holtgrave DR. Costs and consequences of the US Centers for Disease Control and Prevention's recommendation for opt-out HIV testing. PLoS Medicine 2007;4:e194 (online electronic journal)
Holtgrave DR, Kates J. HIV incidence and CDC's HIV prevention budget: An explatory correlational analysis. American Journal of Preventive Medicine. Epub ahead of print, 2006 Dec.
Holtgrave DR. Curran JW. What Works, and What Remains to Be Done, in HIV Prevention in the United States. Annual Review of Public Health. 27:261-275, 2006.
Holtgrave DR. Causes of the Decline in AIDS Deaths, United States, 1995-2002: Prevention, Treatment or Both? International Journal of STD & AIDS. 16(12)777-781, 2005 Dec.
Holtgrave DR. Crosby RA. Is Social Capital a Protective Factor Against Obesity and Diabetes? Findings from an Exploratory Study. Annals of Epidemiology. 16(5):406-408, 2006 May.
Holtgrave DR. Using Economic Threshold Analysis to Determine the Intensity of HIV Prevention Services for HIV Seropositive Persons. AIDS. 19(17):2025-2039, 2005 Nov.
Salazar L, Crosby RA, Holtgrave DR, Frew P, Peterson J. Issues related to gay and bisexual men's acceptance of a future AIDS vaccine. International Journal of STD & AIDS. 16(8):546-548, 2005 Aug.
Crosby RA, Holtgrave DR. The protective value of social capital against teen pregnancy: A state-level analysis. Journal of Adolescent Health. 38(5): 556-559, 2006 May.
Holtgrave DR. HIV prevention, cost-utility analysis, and race/ethnicity: Methodological considerations and recommendations. Medical Decision Making 24(2):181-191, 2004.